Ketoblink Cream contains Ketoconazole 2% w/w, an antifungal agent indicated for the treatment of various superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Ketoconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. This topical formulation is suitable for use on affected areas such as the trunk, limbs, and scalp. Ketoblink Cream is typically applied once or twice daily to the cleansed and dried skin, with the duration of therapy depending on the severity and type of infection, generally ranging from 2 to 4 weeks. It is important to continue treatment for the full prescribed duration, even if symptoms improve earlier, to prevent recurrence. Ketoblink Cream is well tolerated; however, mild local adverse reactions such as burning, itching, or irritation may occur. It should be used with caution in patients with known hypersensitivity to ketoconazole or any excipients in the formulation. Ketoblink Cream is not recommended for use in mucous membranes or open wounds. Consult a healthcare professional before use during pregnancy or lactation.